{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:27Z","timestamp":1789977327586,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.015","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T02:33:50Z","timestamp":1445740430000},"page":"6178-6185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children"],"prefix":"10.1016","volume":"33","author":[{"given":"Emmanuelle","family":"Varon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"B\u00e9chet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Doit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2015.10.015_bib0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.015_bib0215","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/infdis\/142.6.923","article-title":"Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life","volume":"142","author":"Gray","year":"1980","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.015_bib0220","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.015_bib0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.10.015_bib0230","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/INF.0b013e3182788fdd","article-title":"Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine","volume":"32","author":"Sharma","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.015_bib0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.015_bib0240","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1128\/IAI.73.1.431-435.2005","article-title":"Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland","volume":"73","author":"Hanage","year":"2005","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.015_bib0245","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.inf.0000220231.79968.f6","article-title":"Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis","volume":"25","author":"Shouval","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.015_bib0250","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.10.015_bib0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001\u20132012","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.10.015_bib0260","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/INF.0000000000000451","article-title":"Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France","volume":"33","author":"Levy","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.015_bib0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2015.10.015_bib0270","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.015_bib0275","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12325-013-0051-2","article-title":"A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis","volume":"30","author":"Tin Tin Htar","year":"2013","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.015_bib0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.015_bib0285","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.015_bib0290","doi-asserted-by":"crossref","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","article-title":"Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S., aureus, H. influenzae and M. catarrhalis","volume":"7","author":"Spijkerman","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2015.10.015_bib0295","doi-asserted-by":"crossref","first-page":"20750","DOI":"10.2807\/1560-7917.ES2014.19.12.20750","article-title":"Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012","volume":"19","author":"Aguiar","year":"2014","journal-title":"Euro Surveill"},{"issue":"27","key":"10.1016\/j.vaccine.2015.10.015_bib0300","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance","volume":"32","author":"Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.015_bib0305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.arcped.2013.05.016","article-title":"Annual trends (2008\u20132011) in early childhood vaccination coverage for the French population: the Vaccinoscopie((R)) study","volume":"20","author":"Martinot","year":"2013","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.vaccine.2015.10.015_bib0310","series-title":"French vaccinal calendar recommendations","author":"Anonymous","year":"2010"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.015_bib0315","doi-asserted-by":"crossref","first-page":"e90935","DOI":"10.1371\/journal.pone.0090935","article-title":"Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France","volume":"9","author":"Janoir","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.015_bib0320","series-title":"NRCP report 2013","article-title":"2012 Epidemiology","author":"Varon","year":"2013"},{"issue":"11","key":"10.1016\/j.vaccine.2015.10.015_bib0325","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/IAI.71.11.6192-6198.2003","article-title":"Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides","volume":"71","author":"van Selm","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2015.10.015_bib0330","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/505710","article-title":"Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children","volume":"194","author":"Sleeman","year":"2006","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2015.10.015_bib0335","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.015_bib0340","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/JCM.00275-06","article-title":"Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004","volume":"44","author":"Kronenberg","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.015_bib0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3346\/jkms.2013.28.1.4","article-title":"Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance","volume":"28","author":"Song","year":"2013","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2015.10.015_bib0350","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.015_bib0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2334-8-81","article-title":"Molecular epidemiology of pneumococci obtained from Gambian children aged 2\u201329 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine","volume":"8","author":"Antonio","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.015_bib0360","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.meegid.2011.08.016","article-title":"Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing","volume":"11","author":"Rakov","year":"2011","journal-title":"Infect Genet Evol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.10.015_bib0365","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/ciu366","article-title":"Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009\u20132011","volume":"59","author":"Schillberg","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.015_bib0370","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2015.10.015_bib0375","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","volume":"32","author":"van Hoek","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.015_bib0380","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1183\/09031936.00080814","article-title":"Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types","volume":"44","author":"Browall","year":"2014","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.vaccine.2015.10.015_bib0385","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.01763-10","article-title":"Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype","volume":"49","author":"Sa-Leao","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.015_bib0390","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.015_bib0395","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/jac\/dkv061","article-title":"Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011\u201313","volume":"70","author":"Golden","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.015_bib0400","first-page":"629","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.015_bib0405","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.015_bib0410","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/INF.0b013e31820a5adb","article-title":"Blood cultures in the emergency department evaluation of childhood pneumonia","volume":"30","author":"Shah","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T03:53:27Z","timestamp":1653364407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15014309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":41,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15014309"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}